A novel algorithm for network-based prediction of cancer recurrence.
Jianhua Ruan1, Md Jamiul Jahid2, Fei Gu3
1Department of Computer Science, University of Texas, San Antonio, TX, USA; Department of Molecular Medicine, University of Texas Health Science Center, San Antonio, TX, USA; Department of Electrical Engineering and Computer Science, McNeese State University, Lake Charles, LA, USA.
Genomics
|July 26, 2016
Summary
This study introduces a new computational method to identify gene subnetworks for predicting cancer recurrence. The approach effectively uses epigenetic connectors and differentially methylated genes to improve prognostic accuracy in endometrial cancer.
Area of Science:
- Computational biology
- Cancer genomics
- Epigenetics
Background:
- Developing accurate prognostic models is crucial in omics-based cancer research.
- Identifying reliable biomarkers for cancer recurrence prediction remains a significant challenge.
Purpose of the Study:
- To propose a novel computational method for identifying dysregulated gene subnetworks as biomarkers.
- To predict cancer recurrence using DNA methylome data.
Main Methods:
- Applied a novel computational method to the DNA methylome of endometrial cancer patients.
- Identified Epigenetic Connectors (ECs) topologically connecting differentially methylated (DM) genes in a protein-protein interaction network.
- Combined DM genes and ECs using a random walk procedure for feature selection.
Main Results:
- Identified a significant subnetwork of ECs enriched in tumorgenesis and metastasis pathways.
- Constructed a support vector machine classifier that significantly improved cancer recurrence prediction accuracy.
- The network-based approach outperformed several alternative prediction methods.
Conclusions:
- The proposed network-based computational method effectively identifies gene subnetworks for cancer recurrence prediction.
- Epigenetic Connectors play a vital role in linking differentially methylated genes for improved prognostic modeling.
- This approach demonstrates significant potential for advancing omics-based cancer research and clinical applications.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
812
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
812
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K


